CCAIM
Novel AI to transform healthcare
The International Conference on Learning Representations (ICLR) 2021 has accepted a paper representing landmark research from the van der Schaar Lab. The paper is entitled Clairvoyance: A Pipeline Toolkit for …
The Cambridge Centre for AI in Medicine develops pioneering AI and machine learning technologies with the goal of transforming biomedical science, medicine and healthcare. Another of our goals is to …
We are looking for an accomplished and multitalented Centre Coordinator and Project Manager for the opportunity to develop and shape the role to support the newly established Cambridge Centre for …
The Cambridge Centre for AI in Medicine is excited to announce our free Inaugural Event! It will take place online on 22 January 2021, from 2pm to 6pm GMT (9am to …
The Cambridge Centre for AI in Medicine is a multi-disciplinary centre established by the University of Cambridge in 2020 to develop pioneering AI machine learning (ML) technologies that will transform …
Today the University of Cambridge announces a five-year agreement with AstraZeneca and GSK to fund the Cambridge Centre for AI in Medicine (CCAIM). For the 5-year duration, AstraZeneca and GSK …
The question of which patient should receive a life-saving donor organ is one of the thorniest in medicine. Donor organs are a scarce resource, each one as unique as the …
Four members of the 10-strong CCAIM faculty have clocked up a total of 18 papers accepted at NeurIPS 2020 – one of the most prestigious international conferences for AI and …
CCAIM Co-Director Andres Floto, pictured above outside Royal Papworth Hospital in Cambridge, is leading a study on home monitoring for people with cystic fibrosis. The research is central to Project …
World-leading AI technology developed at the University of Cambridge by the directors of the Cambridge Centre for AI in Medicine and their colleagues offers a glimpse of the future of …
World-leading machine learning (ML) technology developed at the University of Cambridge promises powerful new prediction and analytical tools to support the clinical care of individuals with the life-limiting condition. The …
The coronavirus pandemic is the greatest global healthcare crisis of our generation, presenting enormous challenges to medical research, including clinical trials. Advances in Machine Learning are providing an opportunity to …
The first international standards for the design and reporting of clinical trials involving artificial intelligence have been announced in a move experts hope will tackle the issue of overhyped studies …
“Machine learning has the potential to catalyze a complete transformation in healthcare, but researchers in our field are still hamstrung by a lack of access to high-quality data, which is …
The van der Schaar lab, led by CCAIM’s Director, Professor Mihaela van der Schaar, has published a major new thought piece on automated machine learning (AutoML). AutoML will be the …
This week, CCAIM Co-Director, Professor Andres Floto features in the Science, Policy and Pandemics podcast, a panel-based discussion programme produced by the University of Cambridge Centre for Science and Policy …
The lab led by the Director of the Cambridge Centre for AI in Medicine, Professor Mihaela van der Schaar, has had 7 papers accepted for ICML 2020, which kicks off …
CCAIM Director, Mihaela van der Schaar, will deliver a tutorial at the 2020 Machine Learning Summer School to be hosted by the Max Planck Institute for Intelligent Systems from June 28 …
A University of Cambridge team led by Professor Mihaela van der Schaar and intensive care consultant Dr Ari Ercole of the Cambridge Centre for AI in Medicine (CCAIM) is calling …
How the Centre’s network of leading scientists and clinicians is deploying pioneering AI and machine learning on multiple fronts to help fight the coronavirus pandemic. The coronavirus pandemic has galvanised …
Centre Director, Professor Mihaela van der Schaar discusses with the Centre for Data Innovation the challenges and opportunities for machine learning in medicine and her lab’s recent partnership with NHS …
Sarah Teichmann, a Principal Investigator for CCAIM and Head of Cellular Genetics at the Wellcome Sanger Institute, is recognised for her pioneering computational biology and genomics work, which led to …
Centre Director, Professor Mihaela van der Schaar, announces a breakthrough: a partnership between her Cambridge lab and NHS Digital and Public Health England, to trial Cambridge Adjutorium – a system …
CCAIM Director, Professor Mihaela van der Schaar, explains that using AI and machine learning in medicine isn’t just about developing accurate models and rolling them out because, on their own, …
